The Lipidomic Profile Discriminates Between MASLD and MetALD
Alimentary Pharmacology & Therapeutics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 11, 2025
ABSTRACT
Background
The
recent
consensus
statement
redefined
steatotic
liver
diseases.
Metabolic
dysfunction‐associated
disease
(MASLD)
and
metabolic
dysfunction
alcohol‐related
(MetALD)
now
represent
distinct
entities.
However,
biomarkers
that
differentiate
MASLD
MetALD
remain
largely
unknown.
Aims
To
identify
lipidomic
with
discriminatory
potential
for
distinguishing
from
MASLD.
Methods
Using
the
UK
Biobank
dataset,
40,534
people
available
MRI
scans
were
analysed.
A
total
of,
11,217
cases
a
proton
density
fat
fraction
(PDFF)
≥
5%
identified
as
having
disease.
Among
these,
profiles
obtained
5539
462
cases.
250
plasma
metabolomic
parameters
Mendelian
randomisation
(MR)
analysis
was
used
to
confirm
association
between
alcohol
consumption
biomarkers.
Results
When
comparing
top
30
differentially
expressed
predicting
compared
MASLD,
majority
related
HDL
significantly
overrepresented
at
both
analysed
time
points.
five
metabolites
were:
acetoacetate,
3‐hydroxybutyrate,
phospholipids
in
Large
HDL,
concentration
of
large
particles,
free
cholesterol
HDL.
sensitivity
revealed
similar
associations,
suggesting
signature
is
stable
over
time.
Additionally,
MR
further
confirmed
associated
increased
levels
HDL‐related
metabolites.
Conclusion
Our
findings
indicate
HDL‐centric
markers,
particularly
those
within
larger
medium
subfraction,
may
Further
longitudinal
experimental
studies
are
warranted
validate
these
assess
their
clinical
implications.
Language: Английский
Attention to the misuse of Mendelian randomisation in medical research
eGastroenterology,
Journal Year:
2025,
Volume and Issue:
3(1), P. e100187 - e100187
Published: Feb. 1, 2025
Language: Английский
Examining the link between 179 lipid species and 7 diseases using genetic predictors
EBioMedicine,
Journal Year:
2025,
Volume and Issue:
114, P. 105671 - 105671
Published: March 30, 2025
Language: Английский
Association of free triiodothyronine and total triiodothyronine with nonalcoholic fatty liver disease: from National Health and Nutrition Examination Survey and Mendelian randomization study
Wei Hao,
No information about this author
Lanlan Chen,
No information about this author
Ting Li
No information about this author
et al.
European Journal of Gastroenterology & Hepatology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 5, 2025
Background
Nonalcoholic
fatty
liver
disease
(NAFLD)
is
associated
with
multiple
factors,
yet
the
relationship
between
NAFLD
and
thyroid-related
biomarkers
remains
unclear.
This
study
aims
to
elucidate
this
potential
linkage.
Methods
Utilizing
data
from
US
National
Health
Nutrition
Examination
Survey
(NHANES),
we
explored
possible
associations
through
multivariable
logistic
regression,
subgroup
analysis,
interaction
tests.
A
bidirectional
Mendelian
randomization
(MR)
approach
complemented
by
various
sensitivity
analyses
was
then
employed
ascertain
these
relationships’
causality.
Results
Our
NHANES
analysis
indicated
significant
elevated
levels
of
free
triiodothyronine
(FT3)
[odds
ratio
(OR):
2.59,
95%
confidence
interval
(CI):
1.50–4.49]
total
(TT3)
(OR:
2.01,
CI:
1.27–3.18)
prevalence
NAFLD.
MR
findings
reinforced
causal
relationship,
demonstrating
that
may
elevate
FT3
(
β
:
0.05,
0.01–0.09)
TT3
0.08,
0.02–0.14)
levels.
Additionally,
thyroid-stimulating
hormone
(TSH)
confirmed
as
an
independent
risk
factor
for
1.10,
1.04–1.18),
specific
supporting
robustness
results.
Conclusion
indicates
elevations
in
FT3,
TT3,
thyroglobulin
NAFLD,
while
also
identifying
TSH
a
These
underscore
importance
routine
thyroid
function
monitoring
both
general
population
particularly
individuals
Language: Английский